Other blood glucose lowering drugs, excl. Insulins

PheWeb

GLUCLOW_OTH

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC A10BX

6905

Check pre-conditions, main-only, mode, ICD version None

4069

Check minimum number of events

Min. number of events 3

4069

Include endpoints None

4069

GLUCLOW_OTH

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Other blood glucose lowering drugs, excl. Insulins based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	3958	2053	1905
Unadjusted prevalence (%)	1.28	1.18	1.41
Mean age at first event (years)	58.21	57.31	59.18

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.02	1.18 [0.85, 1.64]	3.1e-1	472
15 years	0.01	0.91 [0.69, 1.20]	5.0e-1	229
5 years	0.00	1.70 [1.32, 2.20]	4.4e-5	111
1 year	0.00	0.94 [0.51, 1.74]	8.4e-1	11

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: GLUCLOW_OTH – Other blood glucose lowering drugs, excl. Insulins
GWS hits:

Survival analyses between endpoints

↥

Plot

before Other blood glucose lowering drugs, excl. Insulins
after Other blood glucose lowering drugs, excl. Insulins

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Other blood glucose lowering drugs, excl. Insulins

↥